News | May 14, 2014

OrbusNeich Launches Sapphire II NC Coronary Dilatation Catheter

Balloon catheter engineered to optimize treatment of tight lesions

May 14, 2014 — OrbusNeich announced the launch of the Sapphire II NC coronary dilatation catheter, a non-compliant balloon catheter engineered to cross tight lesions, outside the United States.

Sapphire II NC’s proprietary balloon processing results in an excellent crossing profile for primary and repeated lesion entry. The enhanced distal Z-Tip with advanced laser welding technology results in “zero” transition between the distal leading tip and conventional steerable guidewires. Sapphire II NC is available in a broad range of sizes, from 1.75 mm to 5 mm, with a catheter working length of 140 cm.

Dr. Toshiya Muramatsu of the Saiseikai Yokohama-City Eastern Hospital in Japan said, “Sapphire II NC with its reduced and improved profile performs well not just as a post but also as a pre dilatation balloon. Robustness and good crossability are very desirable features for a non-compliant balloon."

For more information: www.OrbusNeich.com


Related Content

News | Balloon Catheter

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
Subscribe Now